awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35132525-F9F6561F-D701-4273-8572-072413A3770D
Q35132525-F9F6561F-D701-4273-8572-072413A3770D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35132525-F9F6561F-D701-4273-8572-072413A3770D
A phase I/II study of the Janus kinase (JAK)1 and 2 inhibitor ruxolitinib in patients with relapsed or refractory acute myeloid leukemia
P2860
Q35132525-F9F6561F-D701-4273-8572-072413A3770D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35132525-F9F6561F-D701-4273-8572-072413A3770D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
694f14c3886a0241b54d82a567d36a0c2dd9aff7
P2860
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.